937 related articles for article (PubMed ID: 26339893)
21. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients.
Villalba WO; Sampaio-Barros PD; Pereira MC; Cerqueira EM; Leme CA; Marques-Neto JF; Paschoal IA
Chest; 2007 Jan; 131(1):217-22. PubMed ID: 17218579
[TBL] [Abstract][Full Text] [Related]
22. Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.
Moore OA; Proudman SM; Goh N; Corte TJ; Rouse H; Hennessy O; Morrisroe K; Thakkar V; Sahhar J; Roddy J; Youssef P; Gabbay E; Nash P; Zochling J; Stevens W; Nikpour M
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S111-6. PubMed ID: 26243401
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
[TBL] [Abstract][Full Text] [Related]
24. Detection of interstitial lung disease in systemic sclerosis through partitioning of lung transfer for carbon monoxide.
Pernot J; Puzenat E; Magy-Bertrand N; Manzoni P; Gondouin A; Bourdin H; Simon-Rigaud ML; Regnard J; Degano B
Respiration; 2012; 84(6):461-8. PubMed ID: 22301769
[TBL] [Abstract][Full Text] [Related]
25. Exercise-Induced Oxygen Desaturation during the 6-Minute Walk Test.
Gupta R; Ruppel GL; Espiritu JRD
Med Sci (Basel); 2020 Jan; 8(1):. PubMed ID: 32023887
[TBL] [Abstract][Full Text] [Related]
26. A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD.
Ora J; Calzetta L; Pezzuto G; Senis L; Paone G; Mari A; Portalone S; Rogliani P; Puxeddu E; Saltini C
Respir Med; 2013 Dec; 107(12):2014-21. PubMed ID: 24161677
[TBL] [Abstract][Full Text] [Related]
27. Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?
Sobiecka M; Lewandowska K; Kober J; Franczuk M; Skoczylas A; Tomkowski W; Kuś J; Szturmowicz M
Lung; 2020 Jun; 198(3):547-554. PubMed ID: 32206858
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters.
Fischer A; Swigris JJ; Bolster MB; Chung L; Csuka ME; Domsic R; Frech T; Hinchcliff M; Hsu V; Hummers LK; Gomberg-Maitland M; Mathai SC; Simms R; Steen VD
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-109-14. PubMed ID: 25372796
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of six-minute walk test in systemic sclerosis.
Rizzi M; Radovanovic D; Santus P; Airoldi A; Frassanito F; Vanni S; Cristiano A; Sarzi-Puttini P; Atzeni F
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):161-167. PubMed ID: 30277863
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of changes in oxyhemoglobin saturation during walking and cycling tests in COPD.
Chuang ML; Lin IF; Chen SP
Respir Care; 2014 Mar; 59(3):353-62. PubMed ID: 23942752
[TBL] [Abstract][Full Text] [Related]
32. Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.
Le Gouellec N; Duhamel A; Perez T; Hachulla AL; Sobanski V; Faivre JB; Morell-Dubois S; Lambert M; Hatron PY; Hachulla E; Béhal H; Matran R; Launay D; Remy-Jardin M
PLoS One; 2017; 12(8):e0181692. PubMed ID: 28763468
[TBL] [Abstract][Full Text] [Related]
33. The 1-minute sit-to-stand test to detect desaturation during 6-minute walk test in interstitial lung disease.
Oishi K; Matsunaga K; Asami-Noyama M; Yamamoto T; Hisamoto Y; Fujii T; Harada M; Suizu J; Murakawa K; Chikumoto A; Matsuda K; Kanesada H; Kikuchi Y; Hamada K; Uehara S; Suetake R; Ohata S; Murata Y; Yamaji Y; Sakamoto K; Ito K; Osoreda H; Edakuni N; Kakugawa T; Hirano T; Yano M
NPJ Prim Care Respir Med; 2022 Jan; 32(1):5. PubMed ID: 35087054
[TBL] [Abstract][Full Text] [Related]
34. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
[TBL] [Abstract][Full Text] [Related]
35. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
Liu QX; Zheng JP; Xie YQ; Guan WJ; Jiang CY; An JY; Yu XX; Liu WT; Gao Y
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):510-5. PubMed ID: 24262087
[TBL] [Abstract][Full Text] [Related]
36. Oxygen desaturation during a 6-minute walk test as a predictor of maximal exercise-induced gas exchange abnormalities in sarcoidosis.
Chenivesse C; Boulanger S; Langlois C; Wemeau-Stervinou L; Perez T; Wallaert B
J Thorac Dis; 2016 Aug; 8(8):1995-2003. PubMed ID: 27621852
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary Hemodynamics and Six-Minute Walk Test Outcomes in Patients with Interstitial Lung Disease.
Nishiyama O; Yamazaki R; Sano H; Iwanaga T; Higashimoto Y; Kume H; Tohda Y
Can Respir J; 2016; 2016():3837182. PubMed ID: 27445533
[TBL] [Abstract][Full Text] [Related]
38. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
40. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
